Background Data on convalescent plasma therapy (CPT) in patients of hematological
malignancies with severe Covid-19 is scarce. Objective To study 14-day mortality in patients who …

Background: Remission induction is the most intensive phase of acute myeloid leukemia (AML)
treatment, associated with significant morbidity and mortality. Collaborative research and …

Accurate quantification of plasma cells in bone marrow samples is essential for the diagnosis,
classification and prognosis of plasma-cell dyscrasias. Published comparisons between …

Daunorubicin and Cytarabine (DA; 3 + 7) has been the standard frontline Acute Myeloid
Leukemia (AML) induction regimen resulting in Complete Remission (CR) rates of 50–70%. It is …

Autologous stem cell transplant (ASCT) is standard consolidation therapy in management of
multiple myeloma (MM) patients. We reviewed records of all consecutive MM patients who …

Background Although autoimmune lymphoproliferative syndrome (ALPS) is an unusual and
fatal disorder to which no absolute cure stands, there also remains substantial diversity with …

Adherence to imatinib (IM) is of utmost importance in patients with chronic myeloid leukemia
(CML) to maximise treatment effectiveness. The main objective is to measure adherence to …

Ganzel I et al i ([4]), reported transient benefit of daratumumab in a multiply relapsed paediatric
Ph-positive B-ALL patient, including failure of anti-CD19 and anti-CD22 chimeric antigen …

Justification Practitioners and people need information about the therapeutic potential of
umbilical cord blood stem cells and pros and cons of storing cord blood in public versus private …

Both elderly acute myeloid leukemia (AML) patients and those with baseline infections,
when treated with intensive chemotherapy, are associated with high induction mortality. We …